ELAN Elanco Animal Health Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ELAN

Price (delayed)

$31.13

Market cap

$14.7B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.27

Enterprise value

$20.32B

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, ...

Highlights

ELAN's equity has soared by 53% YoY
Elanco Animal Health's revenue has increased by 12% from the previous quarter and by 7% YoY
The debt has soared by 160% year-on-year
Elanco Animal Health's net income has plunged by 127% from the previous quarter

Key stats

What are the main financial stats of ELAN
Market
Shares outstanding
472.17M
Market cap
$14.7B
Enterprise value
$20.32B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.73
Price to sales (P/S)
4.2
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.21
Earnings
Revenue
$3.27B
EBIT
-$522.2M
EBITDA
-$5.3M
Free cash flow
-$279.2M
Per share
EPS
-$1.27
Free cash flow per share
-$0.63
Book value per share
$17.96
Revenue per share
$7.42
TBVPS
$11.51
Balance sheet
Total assets
$17.69B
Total liabilities
$9.22B
Debt
$6.13B
Equity
$8.48B
Working capital
$1.34B
Liquidity
Debt to equity
0.72
Current ratio
1.65
Quick ratio
0.76
Net debt/EBITDA
-1,060.66
Margins
EBITDA margin
-0.2%
Gross margin
49.1%
Net margin
-17.1%
Operating margin
-16%
Efficiency
Return on assets
-4.1%
Return on equity
-7.4%
Return on invested capital
-8.1%
Return on capital employed
-3.3%
Return on sales
-16%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ELAN stock price

How has the Elanco Animal Health stock price performed over time
Intraday
0.65%
1 week
-5.26%
1 month
9.69%
1 year
19.36%
YTD
1.5%
QTD
1.5%

Financial performance

How have Elanco Animal Health's revenue and profit performed over time
Revenue
$3.27B
Gross profit
$1.61B
Operating income
-$522.2M
Net income
-$560.1M
Gross margin
49.1%
Net margin
-17.1%
Elanco Animal Health's net income has plunged by 127% from the previous quarter
The net margin has dropped by 101% since the previous quarter
Elanco Animal Health's operating income has decreased by 20% from the previous quarter
Elanco Animal Health's revenue has increased by 12% from the previous quarter and by 7% YoY

Growth

What is Elanco Animal Health's growth rate over time

Valuation

What is Elanco Animal Health stock price valuation
P/E
N/A
P/B
1.73
P/S
4.2
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.21
The company's EPS has shrunk by 123% QoQ
ELAN's equity has soared by 53% YoY
The price to book (P/B) is 24% higher than the last 4 quarters average of 1.4
ELAN's P/S is 14% above its last 4 quarters average of 3.7
Elanco Animal Health's revenue has increased by 12% from the previous quarter and by 7% YoY

Efficiency

How efficient is Elanco Animal Health business performance
Elanco Animal Health's ROE has plunged by 106% from the previous quarter
The company's return on assets has shrunk by 86% QoQ
The company's return on sales has shrunk by 86% QoQ
Elanco Animal Health's ROIC has plunged by 76% from the previous quarter

Dividends

What is ELAN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ELAN.

Financial health

How did Elanco Animal Health financials performed over time
Elanco Animal Health's total assets is 92% higher than its total liabilities
The company's total liabilities has surged by 168% YoY and by 3.6% QoQ
Elanco Animal Health's total assets has surged by 97% YoY and by 2.6% QoQ
The debt is 28% smaller than the equity
The debt to equity has surged by 71% year-on-year but it has declined by 2.7% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.